Hector Rincon-Arevalo

7PUBLICATIONS
37CO-AUTHORS
Infant and child healthAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 13, 2026
RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.

Hector Rincon-Arevalo, Fabian Halleck, Dorottya Böger

|Nov 10, 2025
Distinct autoreactive CD19<sup>-</sup> plasma cell subsets accumulate in lupus-prone mice.

Van Duc Dang, Franziska Szelinski, Elodie Mohr

|Jun 29, 2025
Distinct expression of CD56 and CD19 marks molecular and functional endotypes of tetanus- versus RBD-specific human bone marrow plasma cells.

Yidan Chen, Franziska Szelinski, Marta Ferreira-Gomes

|May 16, 2024
Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow.

Marta Ferreira-Gomes, Yidan Chen, Pawel Durek

|Oct 20, 2021
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.

Eva Schrezenmeier, Hector Rincon-Arevalo, Ana-Luisa Stefanski

|Jun 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.

Hector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski

Pageof 2